SNPHY is currently developing the following drugs: Stn1013800 Ophthalmic Solution, Stn1013800 Ophthalmic Solution, Stn1013800 Ophthalmic Solution Liquid Base, Without Stn1013800, Latanoprost, De-117B Eye Drops. These drug candidates are in various stages of clinical development as the company works toward FDA approval.